Therapeutic Potential of Niacin in PS19 Tauopathy Mice
Our findings suggest that alterations in hippocampal HCAR2 expression may play a role in tau pathology. Niacin treatment improved motor coordination but did not affect the clasping reflex. In addition, niacin improved expression patterns of structural synaptic proteins. These results indicate that HCAR2 activation may help reduce disease severity. However, further studies are needed to clarify the underlying mechanisms. Overall, this research highlights a novel role for HCAR2 in tauopathies and supports the potential repurposing of existing niacin formulations as a therapeutic approach for Alzheimer's disease.
Authors
- Pablo Martínez (ORCID: https://orcid.org/0000-0003-3496-4652)
- Abigail Wallace
- Disha Soni
- Cristian A Lasagna Reeves
- Henika Patel (ORCID: https://orcid.org/0000-0002-2654-4669)
- Claudia Rangel‐Barajas (ORCID: https://orcid.org/0000-0002-4818-8247)
- Israel Coronel
- Adrian L Oblak
- Miguel Moutinho
- Gary E Landreth
Institutions
- Indiana University School of Medicine
- Indiana University – Purdue University Indianapolis (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70855_102381
- Primary Topic
- Tryptophan and brain disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00